Indication

Streptococcus myositis

**Streptococcus myositis** is a rare, life-threatening bacterial infection of the musculoskeletal system characterized by acute inflammation and progressive necrosis of skeletal muscle tissue. Read more about Streptococcus myositis

15 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Streptococcus myositis therapies.

Showing 10–15 of 15 drugs

Filter & compare in the drug finder →Opens the drug finder with Streptococcus myositis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Streptococcus myositis.

**Streptococcus myositis** is a rare, life-threatening bacterial infection of the musculoskeletal system characterized by acute inflammation and progressive necrosis of skeletal muscle tissue.

Most frequently caused by invasive *Streptococcus pyogenes* (group A Streptococcus) via hematogenous seeding or minor trauma, it primarily targets deep skeletal muscle groups, often sparing overlying superficial tissues initially.

Pathophysiologically, streptococcal exotoxins induce extensive microvascular thrombosis and widespread myonecrosis, typically presenting with severe, localized muscle pain, localized edema, and a rapid decline into systemic inflammatory response syndrome, streptococcal toxic shock syndrome, and hemodynamic collapse.

Personalize your experience

Follow Streptococcus myositis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it